VERSACLOZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Versacloz
A generic version of VERSACLOZ was approved as clozapine by IVAX SUB TEVA PHARMS on November 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERSACLOZ?
- What are the global sales for VERSACLOZ?
- What is Average Wholesale Price for VERSACLOZ?
Summary for VERSACLOZ
International Patents: | 6 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Patent Applications: | 5,220 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in VERSACLOZ? | VERSACLOZ excipients list |
DailyMed Link: | VERSACLOZ at DailyMed |
![VERSACLOZ drug patent expirations Drug patent expirations by year for VERSACLOZ](/p/graph/s/t/VERSACLOZ-patent-expirations.png)
Pharmacology for VERSACLOZ
Drug Class | Atypical Antipsychotic |
US Patents and Regulatory Information for VERSACLOZ
VERSACLOZ is protected by one US patents.
Patents protecting VERSACLOZ
Stable clozapine suspension formulation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VERSACLOZ
See the table below for patents covering VERSACLOZ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 527142 | A stable suspension formulation | ⤷ Sign Up |
European Patent Office | 1646393 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | ⤷ Sign Up |
Spain | 2436213 | ⤷ Sign Up | |
Australia | 2004257556 | A stable clozapine suspension formulation | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2005007168 | ⤷ Sign Up | |
Canada | 2532648 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |